Centro Hospitalar Universitário do Porto - Hospital Geral de Santo Antonio

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Enrolling by invitation	Phase 3	2026-04-17		NCT05667493
A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy	Hereditary Transthyretin-Mediated Amyloid Polyneuropathy	Active, not recruiting	Phase 3	2025-12-04		NCT05071300

Clinical trials